We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+0.05%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$3.55B
AUM Growth
+$59.4M
Cap. Flow
+$77M
Cap. Flow %
2.17%
Top 10 Hldgs %
49.57%
Holding
665
New
156
Increased
155
Reduced
111
Closed
128
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VICI icon
151
VICI Properties
VICI
$29.2B
$2.68M 0.08%
93,500
+16,850
+22% +$484K
WDC icon
152
Western Digital
WDC
$156B
$2.65M 0.07%
+46,305
New +$2.57M
JNJ icon
153
Johnson & Johnson
JNJ
$619B
$2.63M 0.07%
+18,000
New +$2.68M
ZTO icon
154
ZTO Express
ZTO
$18.3B
$2.62M 0.07%
126,151
-56,801
-31% -$1.24M
WOLF icon
155
Wolfspeed
WOLF
$1.43B
$2.62M 0.07%
115,000
+50,000
+77% +$1.29M
ACEL icon
156
Accel Entertainment
ACEL
$998M
$2.61M 0.07%
254,737
CEG icon
157
Constellation Energy
CEG
$93.2B
$2.61M 0.07%
+13,030
New +$2.66M
VST icon
158
Vistra
VST
$47.7B
$2.58M 0.07%
30,000
-10,000
-25% -$837K
NETD
159
DELISTED
Nabors Energy Transition Corp II
NETD
$2.54M 0.07%
241,468
VAC icon
160
Marriott Vacations Worldwide
VAC
$4.28B
$2.54M 0.07%
29,100
-11,700
-29% -$1.11M
MNTN
161
DELISTED
Everest Consolidator Acquisition Corporation
MNTN
$2.46M 0.07%
218,844
AIV
162
Aimco
AIV
$381M
$2.37M 0.07%
285,575
+92,375
+48% +$745K
PTGX icon
163
Protagonist Therapeutics
PTGX
$9.4B
$2.36M 0.07%
68,231
-41,099
-38% -$1.2M
SNDX icon
164
Syndax Pharmaceuticals
SNDX
$1.76B
$2.27M 0.06%
110,454
+2,023
+2% +$42.3K
ABBV icon
165
AbbVie
ABBV
$431B
$2.26M 0.06%
13,195
+12,057
+1,059% +$2M
NBIX icon
166
Neurocrine Biosciences
NBIX
$16.2B
$2.24M 0.06%
16,300
+2,300
+16% +$315K
AEO icon
167
American Eagle Outfitters
AEO
$2.97B
$2.2M 0.06%
+110,000
New +$2.51M
USAR
168
USA Rare Earth Inc
USAR
$4.26B
$2.19M 0.06%
206,973
ADC icon
169
Agree Realty
ADC
$9.5B
$2.18M 0.06%
35,163
+30,763
+699% +$1.82M
APXI
170
DELISTED
APx Acquisition Corp. I Class A Ordinary Share
APXI
$2.18M 0.06%
187,581
MAA icon
171
Mid-America Apartment Communities
MAA
$15.5B
$2.17M 0.06%
15,189
+3,014
+25% +$403K
MSTR icon
172
Strategy Inc
MSTR
$37.2B
$2.16M 0.06%
+15,670
New +$2.26M
HTZ icon
173
PUT
Hertz
HTZ
$638M
$2.15M 0.06%
934,600
+752,700
+414% +$3.83M
KNSA icon
174
Kiniksa Pharmaceuticals
KNSA
$5.97B
$2.13M 0.06%
113,995
+19,500
+21% +$365K
IDYA icon
175
IDEAYA Biosciences
IDYA
$3.49B
$2.11M 0.06%
60,050
+8,005
+15% +$317K

Similar funds

UBS O'Connor's Q2 2024 Portfolio in Review

As of Q2 2024, UBS O'Connor held 665 positions worth $3.55B, up 1.7% from $3.49B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

UBS O'Connor's Q2 2024 filing shows 156 new, 155 increased, 111 reduced and 128 closed positions. Its largest new stake was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M. The largest sale was Pioneer Natural Resource Co., an estimated $638M.

By sector, the portfolio is most concentrated in Energy at 27% of assets, down from 34% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q2 2024 buy was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M.
  • UBS O'Connor added most to HashiCorp, Inc. Class A Common Stock in Q2 2024, an estimated $138M increase.
  • UBS O'Connor's biggest Q2 2024 reduction was Cerevel Therapeutics Holdings, Inc. Common Stock, cutting an estimated $51.2M.
  • UBS O'Connor fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $638M.
  • UBS O'Connor's ten largest holdings make up 50% of its $3.55B portfolio in Q2 2024.
  • UBS O'Connor opened 156 new positions and closed 128 in Q2 2024.
  • UBS O'Connor's portfolio value rose 1.7% quarter-over-quarter to $3.55B.

Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.